Remodeling in atrial fibrillation;Remodeling bei vorhofflimmern

Herz

Volumn 27, Issue 4, 2002, Pages 312-321

  Bosch, Ralph F ^a   Seipel, Ludger ^a   Kühlkamp, Volker ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Action potentials; Atrial fibrillation; Connexins; Ion channels; Remodeling

Indexed keywords

CALCIUM CHANNEL L TYPE; GAP JUNCTION PROTEIN; POTASSIUM CHANNEL; SODIUM CHANNEL;

ACTION POTENTIAL; ARTICLE; CALCIUM CELL LEVEL; DISEASE COURSE; GENE EXPRESSION; HEART ARRHYTHMIA; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; ANIMAL; ELECTROCARDIOGRAPHY; GENETICS; HEART ATRIUM; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMAL; ATRIAL FIBRILLATION; CALCIUM CHANNELS, L-TYPE; CONNEXINS; ELECTROCARDIOGRAPHY; ENGLISH ABSTRACT; GENE EXPRESSION; HEART ATRIUM; HUMAN; POTASSIUM CHANNELS; SUPPORT, NON-U.S. GOV'T; ANIMALS; HEART ATRIA; HUMANS;

EID: 0035995970     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-002-2401-8     Document Type: Article

References (79)

1. Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability
2. Signaling mechanisms involved in atrial tachycardia-induced remodeling probed in an isolated, perfused rabbit heart model
3. to currents
4. Ionic mechanisms of electrical remodeling in human atrial fibrillation
5. Inhomogeneity of cellular refractoriness in human atrium: Factor of arrhythmia?
6. The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs
7. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis
8. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation
9. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation
10. max in guinea pig myocardium
11. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation
12. Ionic mechanisms underlying human atrial action potential properties: Insights from a mathematical model
13. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: Insights from a mathematical model
14. Effects of atrial fibrillation on atrial refractoriness in humans
15. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
16. KACh) in human atrial fibrillation
17. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation
18. Effect of AF induced remodeling on class IC and III drug action: Loss of class III effect by atrial fibrillation
19. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs
20. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs - Electrophysiological remodeling
21. Differential efficacy of L- and T-type channel blockers in preventing tachycardia-induced remodeling in dogs
22. The T-type calcium channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs
23. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial remodeling
24. 2+ channel
25. + channel current
26. Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter
27. + current in a chronic dog model of atrial fibrillation
28. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model
29. Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation
30. Electrical remodeling in atrial fibrillation. Time course and mechanisms
31. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation
32. Modulation of mRNA transcription of cardiac potassium channel genes in human chronic atrial fibrillation
33. 2+-channel, beta-adrenorecptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation
34. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
35. Steady-state and nonsteadystate action potentials in fibrillating canine atrium: Abnormal rate adaptation and its possible mechanisms
36. Inactivation of calcium channel current in the calf cardiac Purkinje fiber. Evidence for voltage and calcium-mediated mechanisms
37. Electrophysiological properties in chronic lone atrial fibrillation
38. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban
39. Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation
40. Inactivation of calcium channels in mammalian heart cells: Joint dependence on membrane potential and intracellular calcium
41. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling
42. Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation
43. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort
44. Properties of transmembrane Ca2+ current at physiological temperatures and relevance to action potential
45. Chronic rapid atrial pacing: Structural, functional and electrophysiological characteristics of a new model of sustained atrial fibrillation
46. 2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation
47. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation
48. The quinidine treatment of auricular fibrillation
49. Remodelling of atrial connexin43 expression in human atrial fibrillation
50. Mathematical analysis of canine atrial action potentials: Rate, regional factors, and electrical remodeling
51. Length of the excitation wave and suspectibility to reentrant atrial arrhythmias in normal conscious dogs
52. Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias
53. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation
54. Protein expression of L-type Ca2+ channel subunits is not reduced in atrial myocardium of patients with atrial fibrillation
55. Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate
56. L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation
57. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes
58. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia
59. Verapamil reduces tachycardia-induced electrical remodeling of the atrial
60. Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation
61. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter
62. Redox changes may underlie the earliest electrical remodelling in human atrial fibrillation
63. 2+ currents and and human atrial fibrillation
64. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation
65. Gap junction remodeling in relation to stabilization of atrial fibrillation in the goat
66. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization
67. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat
68. Delayed rectifier outward current and repolarization in human atrial myocytes
69. + current similar to Kv1.5 cloned channel currents
70. Rapid and slow components of delayed rectifier current in human atrial myocytes
71. Ca(2+) channel modulation by recombinant auxiliary beta subunits expressed in young adult heart cells
72. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, IC, and III drugs: A comparison between hydroquinidine, cibenzoline, fiecainide and d-sotalol
73. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide and dsotalol
74. Atrial fibrillation begets atrial fibrillation: A study in awake, chronically instrumented goats
75. The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation
76. + channels in rat atrium - Electrical remodeling in paroxysmal atrial tachycardia
77. Tachycardia-induced change of atrial refractory period in humans. Rate dependency and effects of antiarrhythmic drugs
78. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation
79. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation